Specify a stock or a cryptocurrency in the search bar to get a summary
Frontage Holdings Corp
1521Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug product development and analysis, and delivery and supply of clinical trial materials; and drug metabolism and pharmacokinetic services. The company also provides early stage clinical/bioequivalence services; absolute bioavailability and human radiolabel studies; and chemistry services, including performing custom synthesis. It operates in the United States, the People's Republic of China, Europe, India, Japan, South Korea, and Australia. The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation operates as a subsidiary of Hongkong Tigermed Co., Limited. Address: 700 Pennsylvania Drive, Exton, PA, United States, 19341
Analytics
WallStreet Target Price
12.07 HKDP/E ratio
48.5Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 1521
Dividend Analytics 1521
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 1521
Stock Valuation 1521
Financials 1521
Results | 2019 | Dynamics |